313,163 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9387 |
5 |
5 |
5 |
5 |
3 |
1 |
5 |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
K |
male |
8 |
4/23/25, 2:05 PM |
313,164 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9204 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
male |
8 |
4/23/25, 2:06 PM |
313,165 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9200 |
5 |
5 |
1 |
5 |
5 |
1 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
female |
8 |
4/23/25, 2:06 PM |
313,166 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9376 |
3 |
5 |
1 |
5 |
5 |
1 |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
K |
male |
8 |
4/23/25, 2:07 PM |
313,167 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9353 |
3 |
5 |
1 |
5 |
5 |
3 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
female |
8 |
4/23/25, 2:07 PM |
313,168 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9336 |
5 |
3 |
5 |
5 |
5 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
female |
8 |
4/23/25, 2:07 PM |
313,169 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9237 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
female |
8 |
4/23/25, 2:08 PM |
313,170 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9317 |
5 |
5 |
3 |
5 |
5 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
K |
female |
8 |
4/23/25, 2:08 PM |
313,171 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9447 |
5 |
3 |
5 |
1 |
5 |
5 |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
female |
8 |
4/23/25, 2:08 PM |
313,172 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9189 |
5 |
1 |
5 |
5 |
5 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
female |
8 |
4/23/25, 2:09 PM |
313,173 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9443 |
5 |
5 |
1 |
3 |
5 |
5 |
3 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
male |
8 |
4/23/25, 2:09 PM |
313,174 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9314 |
5 |
5 |
1 |
3 |
5 |
1 |
1 |
3 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
K |
male |
8 |
4/23/25, 2:10 PM |
313,175 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9192 |
3 |
5 |
3 |
1 |
5 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
male |
8 |
4/23/25, 2:10 PM |
313,176 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9339 |
3 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
male |
8 |
4/23/25, 2:10 PM |
313,177 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9377 |
5 |
5 |
3 |
5 |
5 |
5 |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
K |
female |
8 |
4/23/25, 2:11 PM |
313,178 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9176 |
5 |
5 |
5 |
5 |
5 |
3 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
male |
8 |
4/23/25, 2:11 PM |
313,179 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9230 |
5 |
3 |
3 |
5 |
5 |
3 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
male |
8 |
4/23/25, 2:12 PM |
313,180 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9302 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
K |
male |
8 |
4/23/25, 2:12 PM |
313,181 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9450 |
5 |
5 |
5 |
3 |
5 |
3 |
5 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
male |
8 |
4/23/25, 2:14 PM |
313,182 |
12 |
Edison 1st Grd SE Post-Test 24-25 |
rose, cheryl |
Self-Efficacy Questionnaire (K–2) |
|
9402 |
5 |
1 |
1 |
5 |
5 |
5 |
3 |
5 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
K |
male |
8 |
4/23/25, 2:14 PM |